Improve Medical Instruments Co

Improve Medical Instruments Co FCF CAGR 3Y

The FCF CAGR (3 Year) of Improve Medical Instruments Co (300030.SZ) as of Oct 30, 2026 is 76.63 %.

FCF CAGR 3Y

76.63 %

Last updated:

FCF CAGR (3 Year) of Improve Medical Instruments Co is 2025 76.63 % . FCF CAGR (3 Year) of Improve Medical Instruments Co was 2024 - . It decreases by % lower compared to the previous year.

The Improve Medical Instruments Co FCF CAGR 3Y history

The Improve Medical Instruments Co FCF CAGR 3Y history
YEARFCF CAGR 3YYoY
76.63 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Improve Medical Instruments Co Stock analysis

What does Improve Medical Instruments Co do? Improve Medical Instruments Co., Ltd. generates revenue through clinical care services, testing laboratory operations, and financial leasing of medical equipment. The company sells vacuum blood collection systems, liquid biopsy tubes, automatic blood collection tube detachers, thromboelastometers, reagents, hospital intelligent blood collection management systems, and sub-medical record systems (EMR). Its products are exported to Russia, Saudi Arabia, Brazil, and South Korea, with additional offerings including masks, instruments, and reagents. The firm serves healthcare providers and medical facilities globally through these product lines and services. The company's revenue streams include the sale of medical equipment and related products, as well as financial leasing services for medical devices. Products like vacuum blood collection systems and hospital management systems target hospitals and laboratories, while exports to countries such as Russia and Brazil indicate a focus on international markets. The firm's product portfolio spans diagnostic tools, blood collection solutions, and EMR systems, catering to diverse healthcare needs. Improve Medical Instruments Co., Ltd. provides clinical care and testing laboratory services alongside product sales, with a strong emphasis on exporting medical equipment and reagents. The firm's export markets include Russia, Saudi Arabia, Brazil, and South Korea, where its vacuum blood collection systems, thromboelastometers, and EMR systems are in demand. Revenue is derived from both direct product sales and financial leasing of medical equipment to healthcare institutions. Improve Medical Instruments Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Improve Medical Instruments Co stock

FCF CAGR (3 Year) of Improve Medical Instruments Co is 76.63 % in 2025.

On Eulerpool you can find the complete historical development of FCF CAGR (3 Year) Improve Medical Instruments Co since 2006 – with annual values, charts, and detailed analysis.

The 3-year FCF CAGR shows the compound annual growth rate of free cash flow over three years.

To evaluate FCF CAGR (3 Year)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF CAGR (3 Year).

FCF CAGR (3 Year)'s is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track FCF CAGR (3 Year)'s Improve Medical Instruments Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Improve Medical Instruments Co

All Key Metrics — Improve Medical Instruments Co